Cited by

• Antiparkinson prodrugs.

  Di Stefano A, Sozio P, Cerasa LS. Di Stefano A, et al. Molecules. 2008 Jan 16;13(1):46-68. doi: 10.3390/molecules13010046. Molecules. 2008. PMID: 18259129 Free PMC article. Review.
• Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester.

  Scatton B, Worms P. Scatton B, et al. Naunyn Schmiedebergs Arch Pharmacol. 1978 Jul;303(3):271-8. doi: 10.1007/BF00498054. Naunyn Schmiedebergs Arch Pharmacol. 1978. PMID: 567284
• Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine.

  Campbell A, Baldessarini RJ, Teicher MH, Neumeyer JL. Campbell A, et al. Psychopharmacology (Berl). 1986;88(2):158-64. doi: 10.1007/BF00652233. Psychopharmacology (Berl). 1986. PMID: 3081927
• Improvement of the oral bioavailability of the selective dopamine agonist N-0437 in rats: the in vitro and in vivo activity of eight ester prodrugs.

  den Daas I, Tepper PG, Horn AS. den Daas I, et al. Naunyn Schmiedebergs Arch Pharmacol. 1990 Mar;341(3):186-91. doi: 10.1007/BF00169729. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 1971427
• Regiospecific synthesis of isoapocodeine from 10,11-dimethoxyaporphine by using Cunninghamella elegans.

  Smith RV, Davis PJ. Smith RV, et al. Appl Environ Microbiol. 1978 Apr;35(4):738-42. doi: 10.1128/aem.35.4.738-742.1978. Appl Environ Microbiol. 1978. PMID: 25623 Free PMC article.